当前位置: 首页 > 期刊 > 《中国现代医生》 > 2018年第22期
编号:13284254
二甲双胍治疗氯氮平所致精神分裂症患者体重增加的疗效研究(3)
http://www.100md.com 2018年8月5日 《中国现代医生》 2018年第22期
     [9]Hong CJ,Lin CH,Yu YW,et al. Genetic variant of the histamine-1 receptor(glu349asp) and body weight change during clozapine treatment[J]. Psychiatric Genetics,2002, 12(3):169-171.

    [10]Perdigua SR,Quecuti RS,Mana A,et al. An observational study of clozapine induced sedation and its pharmacological management[J]. Eur Neuropsychopharmacol,2016, 26(1):156-161.

    [11]Rosenman S. Clozapine super sedation[J]. Australian & New Zealand Journal of Psychiatry,2013,47(1):93.

    [12]Chen CH,Huang MC,Kao CF,et al. Effects of adjunctive metformin on metabolic traits in nondiabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight:A 24-week,randomized,double-blind,placebo-controlled study[J].J Clin Psychiatry,2013,74(5):E424.

    [13]Liu Z,Zheng W,Gao S,et al. Metformin for treatment of clozapine-induced weight gain in adult patients with schizophrenia:a meta-analysis[J]. Shanghai Archives of Psychiatry,2015,27(6):331-340.

    [14]金衛东,纪菊英,苏宗荣,等. 氯氮平引起粒细胞缺乏的Meta分析[J]. 上海精神医学,2000,12(1):30-31.

    [15]钟远惠,袁日强,刘舜华,等. 药物结合心理行为治疗精神分裂症伴代谢综合征的效果分析[J]. 中国实用神经疾病杂志,2016,19(2):1-3.

    (收稿日期:2018-04-10), 百拇医药(潘勇)
上一页1 2 3